Full Text
Full Text PDF
Abstract
Cite this article as: Suwabe T, Yamanouchi M, Ubara Y, Sawa N. Long-term effect and safety of tocilizumab on severe adult-onset Still’s disease accompanied by thrombotic thrombocytopenic purpura. Eur J Rheumatol. 2025, 12(4), 0029, doi: 10.5152/eurjrheum.2025.25029.
Article Info
Published In
Journal
European Journal of Rheumatology
Volume / Issue
Volume 12 · Issue 4
Pages
1-2
History
Published Online
December 5, 2025
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright
Copyright (c) 2025 European Journal of Rheumatology
Affiliations
Masayuki Yamanouchi
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Yoshifumi Ubara
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Naoki Sawa
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Cite this Article
Outlines